CD4 and neoplasm: Dendritic cell (DC) therapy is intended to induce the proliferation of T cells and promote the activation of CD4+ and CD8+ T-cells by presenting them with tumor antigens, allowing CD8+ T-cells to infiltrate the tumor microenvironment [63].